Sleep apnea affects a billion people worldwide and can cause serious medical problems, and yet its most widely prescribed therapy can be intolerable for many sufferers. My guest today has identified and jumped on a huge need for an alternative therapy.
We're sitting down with Len Liptak, founder and CEO of ProSomnus Sleep Technology, which trades under the symbol O S A. He's a board member and the co-inventor of the company's flagship product. Prior to starting ProSomnus, Len was President of MicroDental Laboratories, where he led the commercialization of multiple award-winning products and directed the expansion of the company's digital supply chain. During Len's tenure, the company grew three times faster than the industry average and set company records for profitability. At MicroDental, Len was named to Exec Rank's list of Top Executives for privately held companies in 2012 and 2013.
Len also spent 10 years at 3M and Stryker in strategic business development, business unit management and product development capacities. While at 3M, he was awarded the company's Golden Step Award, Circle of Technical Excellence Team Award and Global Sales and Marketing Leadership Award. Len has an MBA from University of Minnesota and a BA from Brown.
We had a great conversation about the important work ProSomnus is doing to solve a widespread medical problem.
Highlights:
- What ProSomnus does, and Len’s background that started him on this path (3:10)
- The problem of sleep apnea (5:05)
- The total addressable market for ProSomnus (7:18)
- ProSomnus’ flagship product and how it differs from traditional treatments (8:33)
- How it’s delivered to patients (10:45)
- The economics of expanding the sales force (12:47)
- Len shares some fascinating survey data about their market (13:51)
- ProSomnus’ manufacturing expansion (15:44)
- How ProSomnus manages quality assurance and their use of AI (18:28)
- ProSomnus’ partnerships for driving innovation forward (20:39)
- How they gather feedback from healthcare providers (23:10)
- Len discusses their growth rate and how that translates through their P & L (25:15)
- Len talks about the great team at ProSomnus (27:14)
Feedback:If you have questions about the show, or have a topic in mind you'd like discussed in future episodes, email our producer,
marion@lowerstreet.co.
What is Welcome to the Arena from ICR – Conversations with Today's Innovators & Business Leaders?
In the increasingly crowded and competitive corporate and financial ecosystem, it’s harder than ever for companies to break through the clutter and be heard. The media, investors, agenda-driven influencers, even customers and competitors, are defining your business story on their terms. Therefore, it is imperative that companies take control and proactively drive the conversation with stakeholders in an effort to build & maintain equity value.
In Welcome to the Arena from ICR, Co-Founder & CEO of ICR, Tom Ryan, interviews key business and financial players who influence the fate of public or aspiring public companies in the capital markets. As a former Wall Street Journal ranked sell-side equity analyst and the founder of one of the largest strategic communications firms in the world, Tom understands what it takes to navigate this complex environment.
This is a forum for CEOs, CFOs, institutional investors, sell-side analysts, financial journalists, private equity professionals and other financial community participants to share their stories and give advice in an open and candid conversation.
For more information, visit http://www.icrinc.com